Truist Securities adjusted its outlook for Sangamo BioSciences, reducing the price target on the company's shares to $5 from ...

Packaging is an attractive offering for many commercial printers looking to tack additional services onto their offerings. Here’s a look at why, plus some insights into current trends and an outlook ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...

ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a clinical-stage biopharmaceutical company with a current market capitalization of $52 million, reported at the Hawaiian Eye and Retina 2025 ...

NDAQ:ATOS) Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

The Nigerian economy is on track for a robust 4.17% growth in 2025, a significant improvement from the 3.36% recorded in 2024 ...

Elevate your email efficiency with these Microsoft Outlook add-ins. From decluttering your inbox to scheduling emails, and ...